Your Expert Partner for Custom Binding Assays and Reagents
Flexible phage solutions.
Precision affinity reagents.
Tango Biosciences leads the industry with an innovative approach to phage display that delivers highly sensitive, specific, and reproducible custom affinity reagents for your target or antigen. Whether you are developing research tools, diagnostic assays, or therapeutics, Tango Biosciences’ sustainable recombinant affinity reagents and assay development solutions deliver more reliable results faster than any other company.
News and Events
-
Michael Scholle Appointed CEO of Tango Biosciences
Co-founder Brian Kay to assume Chief Scientific Officer, focused on scientific innovation and operations CHICAGO–Tango Biosciences, Inc., the premier research partner for custom affinity reagents by phage display, announced Michael Scholle, MS, MBA as Chief Executive Officer effective immediately. Scholle is one of three co-founders of Tango Biosciences and an active board member. This transition enables president…
-
SLAS 2025
Visit Tango Biosciences at the 2025 SLAS International Conference & Exhibition! January 25-29, 2025 | San Diego, CA Booth #2317 Plus, mark your calendar to join our Solution Spotlight presentation or join us for one of two poster presentations: Solution Spotlight: Rapid Phage Display Solutions ideal for SLAS: Screening Ligands for Affinity and Selectivity Tuesday,…
-
NIH SBIR Award
The National Institutes of Health (NIH) awarded a phase I grant to Tango Biosciences in January 2021. This award will support a collaborative effort that generates recombinant antibodies and antibody-like reagents for 6 SARS-CoV-2 viral proteins. These reagents will aid scientists in understanding the function of these viral proteins inside infected cells. Such information may…